Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI)

NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain

BROOMFIELD, Colo., Jan. 31, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the Selby Spine Conference.

Dr. Sigurd Berven, a renowned expert in spinal surgery, will be presenting the latest advancements in technology that are revolutionizing the way we diagnose and treat discogenic pain. NOCISCAN, developed by Aclarion, combines MR spectroscopy with AI to provide a comprehensive analysis of the root cause of back pain, allowing for more targeted and effective treatment plans.

With the growing number of individuals suffering from chronic low back pain, the need for accurate and efficient diagnostic tools has never been greater. Traditional imaging techniques can often be inconclusive, leading to delayed or misdiagnosed conditions. NOCISCAN aims to change that by offering a non-invasive, reliable solution that has the potential to become the new gold standard in identifying discogenic pain.

How Will This Impact Me?

As a patient suffering from chronic low back pain, the introduction of NOCISCAN could mean faster and more accurate diagnosis, leading to improved treatment outcomes and a better quality of life. With the ability to pinpoint the source of my pain, I may be able to receive more targeted therapies and interventions that are tailored to my specific condition.

How Will This Impact the World?

The adoption of NOCISCAN as a standard diagnostic tool for discogenic pain has the potential to revolutionize the way we approach back pain treatment on a global scale. By leveraging the power of AI and advanced imaging technology, healthcare providers around the world can offer more personalized and effective care to their patients, ultimately reducing healthcare costs and improving overall patient outcomes.

Conclusion

In conclusion, the collaboration between Dr. Sigurd Berven and Aclarion, Inc. to showcase the capabilities of NOCISCAN represents a significant step forward in the field of spine care. By combining MR spectroscopy and AI, this innovative technology has the potential to transform the way we diagnose and treat chronic low back pain, setting a new standard of care for patients worldwide.